7. References
[1] F. Bray, J. Ferlay, I. Soerjomataram, R.L. Siegel, L.A. Torre,
A. Jemal, Global cancer statistics 2018: GLOBOCAN estimates of incidence
and mortality worldwide for 36 cancers in 185 countries, CA Cancer J
Clin, 68 (2018) 394-424.
[2] P. Goldstraw, D. Ball, J.R. Jett, T. Le Chevalier, E. Lim, A.G.
Nicholson, F.A. Shepherd, Non-small-cell lung cancer, Lancet, 378 (2011)
1727-1740.
[3] T.J. Lynch, D.W. Bell, R. Sordella, S. Gurubhagavatula, R.A.
Okimoto, B.W. Brannigan, P.L. Harris, S.M. Haserlat, J.G. Supko, F.G.
Haluska, D.N. Louis, D.C. Christiani, J. Settleman, D.A. Haber,
Activating mutations in the epidermal growth factor receptor underlying
responsiveness of non-small-cell lung cancer to gefitinib, N Engl J Med,
350 (2004) 2129-2139.
[4] J.G. Paez, P.A. Janne, J.C. Lee, S. Tracy, H. Greulich, S.
Gabriel, P. Herman, F.J. Kaye, N. Lindeman, T.J. Boggon, K. Naoki, H.
Sasaki, Y. Fujii, M.J. Eck, W.R. Sellers, B.E. Johnson, M. Meyerson,
EGFR mutations in lung cancer: correlation with clinical response to
gefitinib therapy, Science, 304 (2004) 1497-1500.
[5] Y. Dong, H. Chen, J. Gao, Y. Liu, J. Li, J. Wang, Bioactive
Ingredients in Chinese Herbal Medicines That Target Non-coding RNAs:
Promising New Choices for Disease Treatment, Front Pharmacol, 10 (2019)
515.
[6] Z. Cao, L. Liao, X. Chen, L. Lan, H. Hu, Z. Liu, L. Chen, S.
Huang, J. Du, Enhancement of antitumor activity of low-dose
5-fluorouracil by combination with Fuzheng-Yiliu granules in hepatoma 22
tumor-bearing mice, Integr Cancer Ther, 12 (2013) 174-181.
[7] P. Wu, J.J. Dugoua, O. Eyawo, E.J. Mills, Traditional Chinese
Medicines in the treatment of hepatocellular cancers: a systematic
review and meta-analysis, J Exp Clin Cancer Res, 28 (2009) 112.
[8] X. Chen, L. Yang, O.M. Howard, J.J. Oppenheim, Dendritic cells
as a pharmacological target of traditional Chinese medicine, Cell Mol
Immunol, 3 (2006) 401-410.
[9] C. YJ, W. DL, L. CW, D. F, H. LY, C. F, L. WW, Z. C, To explore
the effect of Gefitinib and Brucea javanica oil emulsion (BJOE)for
Advanced Non-small Cell Lung Cancer, Clinical Journal of Chinese
Medicine, 6 (2014) 146-148.
[10] F. Y, Clinical Study of Gefitinib Combined with Compound
Matrine Injection in Treatment of Non-Small Cell Lung Cancer, China
Journal of Chinese Medicine, 28 (2013) 1779-1781.
[11] F. Y, C. SN, Z. JH, J. Y, Z. Y, X. YK, L. JZ, Clinical study of
lung-supplementing and stasis-dissolving decoction (Bufei Huayu Tang)
combined with gefitnib for treatment of advanced non-small cell lung
cancer, Pak. J. Pharm. Sci, 29 (2016) 2185-2189.
[12] F. DZ, Clinical Observation of Renshen Erling Decoction
Integrated with Erlotinib in the Treatment of Advanced Non-Small Cell
Lung Cancer, Chinese Archives of Traditional Chinese Medicine, 31 (2013)
442-443.
[13] G. J, Treatment of 31 cases of non-small cell lung cancer with
modified radix ophiopogonis decoction and gefitinib, Fujian Journal of
TCM, 48 (2017) 4-5.
[14] G. Z, G. P, J. Z, W. YQ, Z. LY, Z. BJ, X. GM, Aiyu Capsules or
Fufang Banmao Capsules combined with icotinib hydrochloride in the
treatment of advanced NSCLC, Chinese Traditional Patent Medicine, 39
(2017) 2263-2269.
[15] G. J, W. N, Observation of Kanglai injection combined with
erlotinib in the treatment of advanced non-small cell lung cancer, Hebei
Medical Journal, 35 (2013) 685-686.
[16] G. Q, Clinical observation of guben xiaocang decoction combined
with gefitinib in the treatment of advanced lung adenocarcinoma with Yin
deficiency and toxic heat, Heilongjiang University Of Chinese Medicine,
(2016).
[17] H. J, G. Y, Y. XH, Y. Q, D. LK, W. H, L. Y, Z. YN, Clinical
study on Yangzheng Xiaoji Capsules combined with erlotinib in treatment
of advanced non-small cell lung cancer, Drugs & Clinic, 33 (2018)
2655-2659.
[18] H. JL, Z. WY, L. YY, Clinical trial of gefitinib tablets
combination with Aidi injection in the treatment of non-small cell lung
cancer in elderly patients, Chin J Clin Pharmacol, 33 (2017) 2013-2015.
[19] H. MN, S. YY, C. J, L. XJ, C. L, Clinical study of tarceva in
combination with Xiaoyantang plus-minus prescriptions in treatment of
non-small cell lung cancer,
Chinese Clinical Oncology, 14 (2009) 622-624.
[20] H. Y, L. FL, Clinical Study of Bufeidingchuan Prescription
Combined Gefitinib Treatment of Advanced Lung Cancer, Guide of China
Medicine, 9 (2011) 23-24.
[21] K. XH, W. LF, W. ZQ, X. ZH, Clinical observation of pulmonary
yanning fang in delaying drug resistance of advanced lung adenocarcinoma
treated with TKIs, Journal of New Chinese Medicine, 44 (2012) 52-54.
[22] L. BJ, Z. RR, Z. Z, Analysis of the Efficacy of Baihegujin
Decoction Combined With Gefitinib in Treatment of Advanced Non-small
Cell Lung Cancer, China Continuing Medical Education, 8 (2016) 195-196.
[23] L. JZ, Clinical study of lung tumor inhibition mixture combined
with erlotinib in the treatment of lung adenocarcinoma, Shandong
University of Traditional Chinese Medicin, (2010).
[24] L. YJ, Clinical Effeet of TCM Terating Advanced Non-small Cell
Lung Caneer Combined with Geiftinib and Analysising sepcialyt of it’s
Tansformation of Clinieal Manifesatitons Shandong University of
Traditional Chinese Medicine, (2016).
[25] L. YX, L. H, X. L, M. LF, Effect of yiqi yangyin decoction
combined with erlotinib on quality of life of patients with advanced
lung adenocarcinoma, Journal of Anhui Traditional Chinese Medical
College, 37 (2018) 39-41.
[26] L. ZX, L. YB, Clinical observation of gefitinib combined with
traditional Chinese medicine in the treatment of local advanced
non-small cell lung cancer, Modern Journal of Integrated Traditional
Chinese and Western Medicine, 26 (2017) 2028-2030.
[27] L. J, L. BP, L. J, W. L, Clinical observation of gefitinib
combined with Aidi injection in the treatment of 80 patients with
advanced non-small cell lung cancer, Chinese Remedies & Clinics, 14
(2014) 957-959.
[28] L. DL, G. FF, W. MM, L. HT, Effect of astragalus polysaccharide
injection combined with gefitinib in the treatment of advanced lung
cancer and its effects on immune function, quality of life and adverse
reactions, Modern Journal of Integrated Traditional Chinese and Western
Medicine, 27 (2018) 4049-4051.
[29] L. H, H. W, W. H, L. HS, Clinical Research on Shenyi Capsule
Combined with Gefitinib for Advanced Non-Small Cell Lung Cancer: A
Report of 50 Cases, Journal of Traditional Chinese Medicine, 53 (2012)
933-936.
[30] L. LF, G. L, L. LJ, G. Y, Clinical study on Cidan Capsules
combined with erlotinib in treatment of advanced non-small cell lung
cancer, Drugs & Clinic, 32 (2017) 2198-2202.
[31] L. WB, L. YC, Clinical effect analysis of TCM syndrome
differentiation combined with gefitinib single drug in the treatment of
advanced non-small cell lung cancer, Modern Diagnosis and Treatment, 27
(2016) 3814-3815+3968.
[32] L. YL, W. J, Clinical effect of TCM syndrome differentiation
combined with gefitinib in the treatment of advanced non-small cell lung
cancer, China Medical Engineering, 22 (2014) 88-89.
[33] L. SJ, Study on the effect and dynamic changes of syndrome of
TCM of Traditional Chinese Medicine combined with Icotinib in treatmeng
of advanced NSCLC, Zhejiang Chinese Medical University, (2015).
[34] Q. J, W. JN, L. YJ, Clinical analysis of compound matrine
combined with gefitinib in the treatment of non-small cell lung cancer,
Guide of China Medicine, 15 (2017) 183-184.
[35] Q. J, Q. SK, Y. LQ, C. YX, S. ZJ, The clinical study of
Gefitnib combination with Kanglaite injection in treatment of
non-small-cell lung cancer, Chinese Clinical Oncology 9(2004) 568-570.
[36] S. PP, Z. YY, S. XH, The Clinical Efficacy and Safety Study of
Non-small-cell Lung Cancer were Targeted for the Treatment of
Non-small-cell Lung Cancer in the Patients with Gastric Control and
Renal Centronine, The Practical Journal of Cancer, 34 (2019) 249-253.
[37] T. CM, Clinical study on the treatment of advanced non-small
cell lung cancer (phlegm-wet lung type) by the combination of
tangcancer-sanjie prescription and Icotinib, Hunan University of Chinese
Medicine, (2017).
[38] T. X, Clinical observation of nourishing Yin and zi
Yinfuzheng_fang combined with gefitinib in the treatment of lung
adenocarcinoma with deficiency of qi and Yin, Hubei University of
Chinese Medicine, (2011).
[39] W. JY, W. SJ, H. L, Z. F, L. CY, K. Y, Clinical trial of
gefitinib tablets combined with Kanglaite capsules in the treatment of
stage ⅢB /Ⅳ non - small cell lung cancer, Chin J Clin Pharmacol, 33
(2017) 1631-1633.
[40] W. TL, O. CS, Y. LN, C. Z, G. HH, Effect of Aidi Injection
Combined with Gefitinib on Tumor Markers in Patients with Non-Small Cell
Lung Cancer, China Pharmaceuticals, 27 (2018) 32-35.
[41] W. XH, C. Z, Effect of xiaoaiping injection combined with
gefitinib on protein expression of Ki67 and p53 in patients with lung
cancer, Modern Journal of Integrated Traditional Chinese and Western
Medicine, 25 (2016) 2683-2685.
[42] W. XL, W. C, Y. L, Clinical observation of gefitinib combined
with pingxiao capsule in the treatment of advanced non-small cell lung
cancer, Journal of Chinese Medicinal Materials, 40 (2017) 724-726S.
[43] W. YH, X. JQ, K. LC, Therapeutic effect of imatinib on advanced
non-small cell lung cancer Shenlingbaizhu granule combined with
gefitinib, Jilin Journal of Traditional Chinese Medicine, 35 (2015)
690-692.
[44] W. WJ, Y. F, L. L, M. YL, Study on the effect of Aidi injection
combined with gefitinib on tumor markers of patients with non-small cell
lung cancer, World Latest Medicne Information (Electronic Version), 18
(2018) 148+150.
[45] W. QX, L. LS, J. Y, S. LP, X. YH, Effect of Chinese Medicine
Treatment Based on Syndrome Differentiation Combined with Icotinib in
Treating Advanced Non-small Cell Lung Cancer, CJITWM, 37 (2017)
1054-1058.
[46] Y. CJ, D. HL, N. GH, F. SQ, Y. JQ, J. XG, Clinical observation
of fuzheng anti-cancer formula combined with gefitinib in patients with
non-small cell lung cancer, Journal of Qiqihar University of Medicine,
37 (2016) 729-730.
[47] Y. LL, Clinical curative effect research on Yifei prescription
combined with Gefitinib in patients with advanced Lung adenocarcinoma,
Nanjing University Of Chinese Medicine, (2017).
[48] Y. WJ, Clinical study on Kanglaite Injection combined with
icotinib in treatment of non-small cell lung cancer, Drugs & Clinic, 31
(2016) 1984-1987.
[49] Y. WQ, W. K, W. H, J. QF, L. JT, Effect of xiaoaiping injection
combined with gefitinib in the treatment of advanced lung
adenocarcinoma, Medical Journal of Wuhan University, 37 (2016) 786-789.
[50] Y. XF, Y. ZF, Z. XL, J. L, G. JH, H. L, H. T, Clinical Study of
Yiqi Yangyin Sanjie Decotion Combined with EGFR-TKIs for EGFR-TKIs
Resistance in Non-small Cell Lung Cancer, Chinese Archives of
Traditional Chinese Medicine, 36 (2018) 442-445.
[51] Y. YJ, G. MF, Effects of astragalus polysaccharide injection
combined with gefitinib on tissue P53 and Ki-67 expressions in patients
with lung cancer,
Chinese Journal of Biochemical Pharmaceutics, 36 (2016) 143-145.
[52] Z. HM, Clinical study of yiqi tongluo detoxification
prescription combined with EGFR-TKI targeted therapy for non-small cell
lung cancer, Anhui University of Chinese Medicine, (2014).
[53] Z. J, H. WJ, W. JG, C. XY, A. ZH, Clinical observation of
xiaoaiping injection combined with Icotunib in treatment of non-small
cell lung cancer, Journal of Hubei College of Traditional Chinese
Medicine, 20 (2018) 42-45.
[54] Z. LJ, H. N, D. YW, Z. JL, F. G, Clinical Observation of
Gefitinib Tablets Combined with Addie Injection in the Treatment of
Advanced Non-Small Cell Lung Cancer with EGFR Positive, Progress in
Modern Biomedicine, 18 (2018) 2696-2700.
[55] Z. M, Clinical Observation of Traditional Chinese Medicine Yiqi
Yangyin Jiedu Decoction Combined with EGFR-TKI in Treatment of
Non-small-cell Lung Cancer,
Anhui Medical University, (2017).
[56] Z. PY, P. JW, The Clinical Research of The Powder for Removing
Rashes United Gefitinib on Adenocarcinoma of Lung, Journal of Chinese
Medicine, 25 (2010) 21-23.
[57] Z. QH, Clinical study of gefitinib combined with elemene
injection for advanced pulmonary adenocarcinoma with EGFR mutation,
Chinese journal of medical frontier, 8 (2016) 113-116.
[58] Z. Q, Y. H, Clinical observation of 78 cases of advanced
non-small cell lung cancer treated by Kanglaite injection combined with
gefitinib, January, 31 (2011) 89-90.
[59] Z. SH, Z. LX, Clinical efficacy of Gefitinib combined with KLT
in treatment of advanced non-small cell lung cancer, Modern Oncology, 22
(2014) 2857-2859.
[60] Z. XW, S. Y, Z. XX, Clinical study of shenlingbaizhu granule
combined with gefitinib/erlotinib in the treatment of advanced non-small
cell lung cancer with spleen qi deficiency, Journal of New Chinese
Medicine, 46 (2014) 127-129.
[61] Z. SH, Y. HT, Z. YN, L. WY, Z. L, Z. CY, Clinical study on
Compound Banmao Capsules combined with gefitinib in treatment of
non-small cell lung cancer, Drugs & Clinic, 33 (2018) 1180-1183.
[62] Z. YJ, Clinical study of tongyang fuzheng decoction combined
with gefitinib in the treatment of advanced non-small cell lung cancer
with unknown EGFR status, Shenzhen Journal of Integrated Traditional
Chinese and Western Medicine, 25 (2015) 41-42.
[63] Y. Zhao, Feiliu Decoction Combined with Icotinib Tablets in the
Treatment of Advanced Lung Cancer 30 cases, Guangming Journal of Chinese
Medicine 32 (2017) 2244-2245.
[64] Z. Y, W. DY, Q. XQ, J. H, F. J, Effect of elemene injection
combined with gefitinib on immune function and life quality of advanced
elder lung cancer patients with EGFR mutant, Chinese Journal of Clinical
Healthcare, 20 (2017) 502-505.
[65] Z. SM, C. Y, W. AJ, Clinical study of gefitinib combined with
brucea javanica oil emulsion injection in the treatment of advanced
non-small cell lung cancer in the elderly, Journal of New Chinese
Medicine, 48 (2016) 158-160.
[66] H. Yueqin, C. Tao, D. Lirong, G. Zipeng, Y. Xueqin, Progression
of Mechanism Research of Active Components of Chinese Medicine in
Anti-Lung Cancer, Journal of Liaoning University of TCM, 12 (2010)
204-206.
[67] S. Qijin, Study on the synergistic effect of aqueous extract
Taxus chinensis combining Erlotinib on human lung carcinoma A549 cells
in COX-2, MMP-2 Expression
Journal of Xinjiang Medical University 36 (2013) 789-792.
[68] K. Junyan, H. Jing, Z. Wanzhen, L. Jun, Z. Zhen, D. Jiyuan,
Inhibitory effect of Xiaoaiping combined with hyperthermia on
gefitinib-resistant human lung cancer A549 cells and expression of
vascular endothelial growth factor Zhejiang Journal of Traditional
Chinese Medicine, 51 (2015) 414-415.
[69] G. Feiyu, Z. Aiqin, S. Yan, Reversal Role of Elemene on
Resistance of Human Lung Adenocarcinoma Cell Line to Gefitinib, Chinese
Archives of Traditional Chinese Medicine 32 (2014) 131-133.
[70] L. M, L. B, X. H, W. F, H. C, L. P, Trans-3,5,4
-trimethoxystilbene reduced gefitinib resistance in NSCLCs via
suppressing MAPK/Akt/Bcl-2 pathway by upregulation of miR-345 and
miR-498, J Cell Mol Med, 23 (2019) 2431-2441.
[71] W. J, Z. P, W. X, Y. Y, Z. G, Z. L, X. Z, L. F, Y. Q, Y. Q, Z.
W, S. J, C. Z, Rab25 promotes erlotinib resistance by activating the
beta1 integrin/AKT/beta-catenin pathway in NSCLC, Cell Proliferation, 52
(2019) e12592.
[72] L. PC, F. YF, Y. H, W. WJ, C. TC, H. X, K. B, X. W, W. Y, Z. Z,
W. Y, K. HP, W. CW, T. CY, C. CH, H. WC, C. SF, N. L, H. J, C. CT, H. L,
Y. WH, D. R, N. K, H. YH, C. SS, C. TJ, T. J, Z. R, W. L, F. B, C. T, W.
KK, H. JL, H. MC, Targeting PKCδ as a Therapeutic Strategy against
Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant
Lung Cancer, Cancer cell, 34 (2018) 954-969.